We assessed the relationship between insulin resistance, serum insulin-like growth factor 1 (IGF-1) levels, and common carotid intima–media thickness (CC-IMT) in morbidly obese young patients. A total of 249 patients (aged 37.9 ± 9.8 years, body mass index [BMI] 45.6 ± 8.3 kg/m2) were evaluated (metabolic tests, serum IGF-1 measurements, homeostasis model assessment—insulin resistance [HOMA-IR], and ultrasonographically assessed CC-IMT) in a research program for bariatric surgery candidates. After adjusting for age, gender, BMI, systolic blood pressure, uric acid, antihypertensive and lipid-lowering treatment, metabolic syndrome, and metabolic class, both HOMA-IR and IGF-1 z-score were significantly associated with CC-IMT. These results were confirmed in logistic regression analysis, in which age (β = 1.11, P = .001), gender (β = 3.19, P = .001), HOMA-IR (β = 1.221, P = .005), and IGF-1 z-score (β = 1.734, P = .009) were the only independent determinants of abnormal CC-IMT, presumably modulating the effect of the other risk factors included in the regression. Area under the receiver–operating characteristic curve for the model was 0.841 (confidence interval: 0.776-0.907; P < .001). In conclusion, in morbidly obese young adults, insulin resistance and IGF-1 z-score are significantly associated with CC-IMT, independent of other major cardiovascular risk factors.
LavieCJMilaniRVVenturaHO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925–1932.
2.
DalmasEKahnJFGiralP. Intima–media thickness in severe obesity: links with BMI and metabolic status but not with systemic or adipose tissue inflammation. Diabetes Care. 2013;36(11):3793–3802.
3.
Recio-RodriguezJIGomez-MarcosMAPatino-AlonsoMC. Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive. BMC Cardiovasc Disord. 2012;12:3.
4.
SteinJHKorcarzCEHurstRT. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima–Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93–111; quiz189–190.
5.
LorenzMWMarkusHSBotsMLRosvallMSitzerM. Prediction of clinical cardiovascular events with carotid intima–media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459–467.
6.
KoskinenJMagnussenCGSabinMA. Youth overweight and metabolic disturbances in predicting carotid intima–media thickness, type 2 diabetes, and metabolic syndrome in adulthood: the Cardiovascular Risk in Young Finns study. Diabetes Care. 2014;37(7):1870–1877.
7.
AndreozziFGastaldelliAManninoGC. Increased carotid intima–media thickness in the physiologic range is associated with impaired postprandial glucose metabolism, insulin resistance and beta cell dysfunction. Atherosclerosis. 2013;229(2):277–281.
8.
DelafontainePSongYHLiY. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol. 2004;24(3):435–444.
9.
BerrymanDEGladCAListEOJohannssonG. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat Rev Endocrinol. 2013;9(6):346–356.
10.
JuulAScheikeTDavidsenMGyllenborgJJorgensenT. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation. 2002;106(8):939–944.
11.
ContiEMusumeciMBDe GiustiM. IGF-1 and atherothrombosis: relevance to pathophysiology and therapy. Clin Sci (Lond). 2011;120(9):377–402.
12.
HietaniemiMPoykkoSMUkkolaOPaivansaloMAntero KesaniemiY. IGF-I concentrations are positively associated with carotid artery atherosclerosis in women. Ann Med. 2005;37(5):373–382.
13.
AmeriPCanepaMFabbiP. Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima–media thickness. Atherosclerosis. 2014;236(2):418–425.
14.
SirbuACopaescuCMartinSBarbuCOlaruRFicaS. Six months results of laparoscopic sleeve gastrectomy in treatment of obesity and its metabolic complications. Chirurgia (Bucur). 2012;107(4):469–475.
15.
Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(suppl 1):S14–S80.
16.
ElmlingerMWKuhnelWWeberMMRankeMB. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med. 2004;42(6):654–664.
17.
MatthewsDRHoskerJPRudenskiASNaylorBATreacherDFTurnerRC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.
18.
National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421.
19.
TouboulPJHennericiMGMeairsS. Mannheim carotid intima–media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290–296.
20.
LorenzMWvon KeglerSSteinmetzHMarkusHSSitzerM. Carotid intima–media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006;37(1):87–92.
21.
ArkinJMAlsdorfRBigorniaS. Relation of cumulative weight burden to vascular endothelial dysfunction in obesity. Am J Cardiol. 2008;101(1):98–101.
22.
TzouWSDouglasPSSrinivasanSR. Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol. 2005;46(3):457–463.
23.
YanRTYanATAndersonTJ. The differential association between various anthropometric indices of obesity and subclinical atherosclerosis. Atherosclerosis. 2009;207(1):232–238.
24.
Recio-RodriguezJIGomez-MarcosMAPatino-AlonsoMC. Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive. BMC Cardiovasc Disord. 2012;12:3.
25.
DrapeauVLemieuxIRichardD. Waist circumference is useless to assess the prevalence of metabolic abnormalities in severely obese women. Obes Surg. 2007;17(7):905–909.
26.
ReavenGM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607.
27.
BornfeldtKETabasI. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575–585.
28.
MariniMAFrontoniSSuccurroE. Insulin clearance is associated with carotid artery intima–media thickness. Atherosclerosis. 2013;229(2):453–458.
29.
BonoraEKiechlSWilleitJ. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study. Diabetes Care. 2007;30(2):318–324.
30.
GastKBSmitJWden HeijerM. Abdominal adiposity largely explains associations between insulin resistance, hyperglycemia and subclinical atherosclerosis: the NEO study. Atherosclerosis. 2013;229(2):423–429.
31.
BertoniAGWongNDSheaS. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2007;30(11):2951–2956.
32.
ViscogliosiGAndreozziPMariglianoV. Associations of plasma glucose levels and traits of metabolic syndrome with carotid intima media thickness in nondiabetic elderly subjects: are they mediated by insulin resistance?Metab Syndr Relat Disord. 2013;11(1):41–45.
LupattelliGDe VuonoSBoniM. Insulin resistance and not BMI is the major determinant of early vascular impairment in patients with morbid obesity. J Atheroscler Thromb. 2013;20(12):924–933.
35.
FriedrichNJorgensenTJuulA. Insulin-like growth factor I and anthropometric parameters in a Danish population. Exp Clin Endocrinol Diabetes. 2012;120(3):171–174.
36.
SavastanoSDi SommaCBarreaLColaoA. The complex relationship between obesity and the somatropic axis: The long and winding road. Growth Horm IGF Res. 2014;24(6):221–226.
37.
ThankamonyACapalboDMarcovecchioML. Low circulating levels of IGF-1 in healthy adults are associated with reduced beta-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting. J Clin Endocrinol Metab. 2014;99(6):2198–2207.
38.
BurgersAMBiermaszNRSchoonesJW. Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J Clin Endocrinol Metab. 2011;96(9):2912–2920.
39.
KawachiSTakedaNSasakiA. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2005;25(3):617–621.
40.
Spilcke-LissEFriedrichNDorrM. Serum insulin-like growth factor I and its binding protein 3 in their relation to intima–media thickness: results of the study of health in Pomerania (SHIP). Clin Endocrinol (Oxf). 2011;75(1):70–75.
41.
WangJNiuWNikiforovY. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest. 1997;100(6):1425–1439.
42.
WangJRazuvaevAFolkersenL. The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation. Atherosclerosis. 2012;220(1):102–109.
43.
LombardiGDi SommaCGrassoLFSavanelliMCColaoAPivonelloR. The cardiovascular system in growth hormone excess and growth hormone deficiency. J Endocrinol Invest. 2012;35(11):1021–1029.
44.
GaloiuSJurcutRVladaiaA. Structural and functional changes of carotid wall properties in patients with acromegaly are not restored after 1 year of GH/IGF1 normalization. Exp Clin Endocrinol Diabetes. 2012;120(4):238–243.
45.
DentiLAnnoniVCattadoriE. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med. 2004;117(5):312–317.
46.
MullerCWallaschofskiHBrabantG. The association between IGF-I/IGFBP-3 and subclinical end points: epidemiology faces the limits. J Clin Endocrinol Metab. 2014;99(8):2804–2812.
47.
FrystykJ. Free insulin-like growth factors—measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res. 2004;14(5):337–375.
48.
ShahASGaoZUrbinaEMKimballTRDolanLM. Prediabetes: the effects on arterial thickness and stiffness in obese youth. J Clin Endocrinol Metab. 2014;99(3):1037–1043.
